您的位置: 首页 > 2018年7月 第49卷 第4期 > 文字全文
2023年7月 第38卷 第7期11
目录

粪菌移植两种肠镜下盲肠置管术的对比研究

Comparison of two types of colonoscopyforfecal microbiota transplantationof cecal catheterization

来源期刊: 广州医药 | 10-12 发布时间:2021-11-29 收稿时间:2025/11/13 17:19:47 阅读量:44
作者:
关键词:
粪菌移植结肠镜盲肠置管术直接肠镜置管法二次肠镜置管法
Fecal microbiota transplantation (FMT)Colonoscopic cecal catheterizationDirect colonoscopy catheterSecondary colonoscopy catheter
DOI:
10.3969/j.issn.1000-8535.2018.04.003
收稿时间:
2018-02-08 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨粪菌移植(FMT)在两种肠镜下盲肠置管术的临床应用。方法 将2016年1月—2017年6月在我院通过肠镜下盲肠置管术进行粪菌移植的200例患者,随机分为A组和B组,各100例。A组采用直接肠镜置管法完成置管,B组采用二次肠镜置管法完成置管,对两组操作的置管成功率、置管时间、平均疼痛评分、并发症等情况进行对比。结果 与A组相比较,B组到达盲肠时间略长但无统计学意义(14.95min vs 15.26min,P=0.68)、疼痛评分低(5.7 vs 4.8,P<0.05)、更低的并发症发生率(6 % vs 23 %,P<0.05)。结论 在粪菌移植内镜下盲肠置管术患者中,采用通过采用二次肠镜置管法与直接肠镜法相比较完成置管手术时间无统计学差异,但置管成功率高、患者的痛苦小、风险低,值得临床推广。
Objective To investigate the clinical application of fecal microbiota transplantation (FMT) in two kinds of colonoscopic cecal catheterization. Methods From January 2016 to June 2017, 200 patients who took colonoscopic cecal catheterization for fecal microbiota transplantation in our hospital were randomly divided into group A and group B, with 100 patients in each group.Group A used direct colonoscopy catheterization to complete catheterization, group B was treated by the second colonoscopy catheterization. The success rate of catheterization, catheterization time, average pain score and complication were compared between the two groups. Results Compared with group A, the time to reach the cecum in group B was slightly longer but not statistically significant (14.95min vs 15.26min,P=0.68). It had lower pain score (5.7 vs 4.8, P<0.05), lower complication rate. Conclusion Among the patients with colonoscopic cecal catheterization for fecal microbiota transplantation, there was no significant difference in the time of catheterization between the second colonoscopy and the direct colonoscopy, but it has the high success rate of catheterization and low pain, low risk, worthy of clinical promotion.
1、 KUNDE S, PHAM A, BONCZYK S, et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis[J]. J Pediatr Gastroenterol Nutr, 2013, 56 (6): 597-601. KUNDE S, PHAM A, BONCZYK S, et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis[J]. J Pediatr Gastroenterol Nutr, 2013, 56 (6): 597-601.
2、 ZHANG F M, WANG H G, WANG M, et al. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease[J]. World J Gastroenterol, 2013, 19 (41):7213-7216. ZHANG F M, WANG H G, WANG M, et al. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease[J]. World J Gastroenterol, 2013, 19 (41):7213-7216.
3、 李超, 谈路轩, 张馨梅,等. 2016年欧洲粪菌移植共识介绍[J]. 胃肠病学和肝病学杂志, 2017, 26(9):961-965. 李超, 谈路轩, 张馨梅,等. 2016年欧洲粪菌移植共识介绍[J]. 胃肠病学和肝病学杂志, 2017, 26(9):961-965.
4、 KAO D,HOTTE N,GILLEVET P,et al. Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile[J]. J Clin Gastroenterol,2014,48 (7): 625-628. KAO D,HOTTE N,GILLEVET P,et al. Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile[J]. J Clin Gastroenterol,2014,48 (7): 625-628.
5、 van NOOD E,VRIEZE A,NIEUWDORP M,et al. Duodenal infusion of donor feces for recurrent Clostridium difficile[J]. N Engl J Med,2013,368 (5): 407-415. van NOOD E,VRIEZE A,NIEUWDORP M,et al. Duodenal infusion of donor feces for recurrent Clostridium difficile[J]. N Engl J Med,2013,368 (5): 407-415.
6、 DAMMAN C J, MILLER S I, SURAWICZ C M, et al. Themicrobiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation[J]. Am J Gastroenterol,2012,107(10):1452-1459. DAMMAN C J, MILLER S I, SURAWICZ C M, et al. Themicrobiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation[J]. Am J Gastroenterol,2012,107(10):1452-1459.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录